Tackling Antimicrobial Resistance: An Interdisciplinary Approach
Lead Research Organisation:
Loughborough University
Department Name: Chemical Engineering
Abstract
The proposal aims to facilitate and encourage multidisciplinary research at Loughborough University (LU) into the healthcare environment (air, water and surfaces) and in community settings (e.g. nursing and care homes, low income countries with high population densities) as potential reservoirs for the transmission of antimicrobial resistant infectious agents. Hospital surfaces are a reservoir for transmission of antimicrobial resistant infectious agents, typically via contamination of the hands of healthcare workers. Staphylococci, C. difficile and Acinetobacter species have been shown to survive many months on high touch near-patient surfaces in healthcare environments. Recent epidemiological evidence suggests that patients admitted to rooms previously occupied by colonised patients have a higher probability of acquiring (i.e. is a risk factor for colonisation or infection) the same pathogen. Other studies have shown aerial dissemination of infectious agents, e.g. C. difficile spores, making it particularly difficult to eradicate infectious agents in hospitals. Despite a recent focus on performance management to improve the efficacy of cleaning and disinfection processes, published studies have demonstrated the presence of culturable indicator organisms (e.g. Methicillin-resistant Staphylococcus aureus and Vancomycin-resistant enterococci) post conventional "terminal disinfection" (i.e. upon patient discharge). Bacterial endospores (e.g. Clostridium difficile) are particularly resilient to routine disinfection treatments due to a variety of factors including use of insufficient, low concentration disinfectant, inadequate contact times etc .The Chief Medical Officer's report highlights issues such as poor design that limits cleaning, poor ventilation and poor water-supply management (risk of Legionella species and Pseudomonas aeruginosa). One of the problems of AMR is the length of time taken to identify pathogens (1-3 days) resulting in (i) potential spread of infectious agents; (ii) antibiotics given to patients unnecessarily 'just in case'. Rapid diagnostics would aid early detection and isolation of patients that would otherwise spread contamination. Photocatalytic self-cleaning surfaces could inactivate infectious agents landing on surfaces thereby breaking the link between contaminated surfaces and transmission through contact. Barriers and levers could be identified to improve hand-hygiene compliance whilst monitoring compliance in real-time using teletracking technology. Novel surface, air and water disinfection systems could be developed e.g. using atmospheric plasma technology. Natural ventilation systems could be designed to improve air quality and reduce dispersal of infectious agents in multi-bed wards. The proposal aims to focus on the following three AMR research themes: (i) Accelerating therapeutic and diagnostics development - Alternative approaches to treat resistant bacteria; New technologies for identifying resistant bacteria to underpin diagnostics development; Scale-up and manufacture of biotherapeutics; The effective delivery of existing antimicrobial agents (ii) Understanding the real world interactions - Understanding the role of the environment as a reservoir for AMR microorganisms and the transmission of infections in community and healthcare environments; Ways to manipulate the environment to prevent transmission (iii) Behaviour within and beyond the healthcare setting - Elucidate underpinning motivations for human behaviours relating to the spread of AMR infectious microorganisms in the healthcare environment and the community; Evaluate interventions to control/prevent the spread of resistant bacteria.
Planned Impact
The proposed Bridging the Gaps bid aims to bring together highly relevant broad academic expertise in the identified AMR research themes : the focus of the project will be on the environment in healthcare and the community, as a reservoir for the transmission of infections. Through cross-sector engagement multidisciplinary research teams will focus on solving clinically-relevant problems. Strong involvement of clinical partners will ensure critical oversight of problem definition so that the ideas that receive funding have the potential to address real-world problems. Problem-led research will be fed through to clinical partners to work jointly on implementation and behaviour change within healthcare organisations. The potential for policy change within public health will be addressed through collaboration with national organisations (e.g. Public Health England). The programme will have strong clinical and industrial steer using its advisory board chaired by Peter Ellingworth (CEO, ABHI) with high level representatives drawn from the NHS (e.g. The Royal Wolverhampton NHS Trust, University Hospitals of Leicester NHS Trust), Charities (e.g. Infection Prevention Society), regional bodies (e.g. East Midlands Infectious Diseases Research Network, EMIDRN) and Industry (e.g. Smith & Nephew, Hygiene Solutions etc). Industrial partners supporting the project will bring a commercial edge to the activities to ensure opportunities for commercialisation are not overlooked. There will be considerable potential for development of new Intellectual Property around innovative technologies, equipment and techniques, and the added benefit of developing these innovations from a multidisciplinary perspective focusing on AMR. The LU Enterprise Office will be engaged at an early stage in the AMR BtG activities to help facilitate knowledge transfer e.g. through 'Innovate UK' funded 'knowledge transfer partnerships', and with intellectual property protection (e.g. early exploration of intellectual property potential of new research ideas through patent applications). The Advisory/Management Group will ensure continued benefit and impact by representing the voices of all stakeholders and guiding the research, as well as providing a path to addressing problems facing healthcare providers in particular. The network will be further developed using the already established network of contacts of the collaborating organisations and their members e.g. leveraging Medilink (EMIDRN), Infection Prevention Society (IPS), ABHI and targeting other related networks e.g. Hospital Infection Society (HIS).
Organisations
- Loughborough University (Lead Research Organisation)
- Cardiff Metropolitan University (Collaboration)
- UNIVERSITY OF LEICESTER (Collaboration)
- August Pi i Sunyer Biomedical Research Institute (Collaboration)
- Cardiff University (Collaboration)
- Royal Wolverhampton Hospitals NHS Trust (Collaboration)
- UNIVERSITY OF BIRMINGHAM (Collaboration)
- Birmingham Community Healthcare NHS Trust (Collaboration)
- Royal Institute of Technology (Collaboration)
- Southport and Ormskirk Hospital NHS Trust (Project Partner)
- Association of British HealthTech Industries (Project Partner)
- The Royal Wolverhampton NHS Trust (Project Partner)
- Infection Prevention Society (Project Partner)
- NHS Lanarkshire (Project Partner)
- Collegium Basilea (Project Partner)
- Smith & Nephew (United Kingdom) (Project Partner)
- University Hospitals of Leicester NHS Trust (Project Partner)
- Hygiene Solutions (Project Partner)
- EMIDRN (Project Partner)
Publications
Alves IP
(2019)
Microfluidic smartphone quantitation of Escherichia coli in synthetic urine.
in Biosensors & bioelectronics
Carpena N
(2021)
Targeted Delivery of Narrow-Spectrum Protein Antibiotics to the Lower Gastrointestinal Tract in a Murine Model of Escherichia coli Colonization.
in Frontiers in microbiology
Cinquerrui S
(2018)
Nanoencapsulation of Bacteriophages in Liposomes Prepared Using Microfluidic Hydrodynamic Flow Focusing.
in Frontiers in microbiology
Clemente A
(2019)
Staphylococcus aureus resists UVA at low irradiance but succumbs in the presence of TiO2 photocatalytic coatings.
in Journal of photochemistry and photobiology. B, Biology
Granja C
(2020)
A quartz crystal resonator for cellular phenotyping
in Biosensors and Bioelectronics: X
Grantham H
(2023)
Transition-Metal-Free Continuous-Flow Synthesis of 2,5-Diaryl Furans: Access to Medicinal Building Blocks and Optoelectronic Materials
in The Journal of Organic Chemistry
Guha A
(2020)
Direct detection of small molecules using a nano-molecular imprinted polymer receptor and a quartz crystal resonator driven at a fixed frequency and amplitude.
in Biosensors & bioelectronics
Guha A
(2019)
Simple and ultrafast resonance frequency and dissipation shift measurements using a fixed frequency drive
in Sensors and Actuators B: Chemical
Guha A
(2022)
Simpler and faster quartz crystal microbalance for macromolecule detection using fixed frequency drive
in Sensors and Actuators B: Chemical
Khobragade S
(2017)
Detection of flexibly bound adsorbate using the nonlinear response of quartz crystal resonator driven at high oscillation amplitude
in Electrochimica Acta
Description | We have developed scalable approaches to manufacture new antibiotics based on bacteriophages and bacteriocins. We have developed processes for the micro- and nanoencapsulation of novel antibiotics for controlled release and targeted delivery for treatment of pulmonary, wound and gastrointestinal infections. We are working with a number of international companies (in confidence) in the pre-clinical phase to develop novel phage based therapeutics for treating bacterial infections and diseases related to disorders of the microbiome. In addition, we have developed novel diagnostic technologies by particle trapping and using nonlinear acoustic methods integrated with microfluidic platforms. |
Exploitation Route | We are working with international companies directly undertaking further related research as well as undertaking consultancy projects related to development of bacteriophages and other advanced biologicals as therapeutics. We have applied for a patent on research arising from the work. We have secured funding for a PhD studentship from a company to further develop the findings of research funded through this grant on microencapsulation of bacteriophages. |
Sectors | Agriculture Food and Drink Healthcare Manufacturing including Industrial Biotechology Pharmaceuticals and Medical Biotechnology |
URL | http://www.lboro.ac.uk/research/amr/ |
Description | We have applied for a patent in the field of nanoencapsulation. We are working with a number of international companies to translate the methods and tools developed during the project related to formulation and encapsulation of biological therapeutics to treat bacterial infections and microbiome related disorders. |
First Year Of Impact | 2018 |
Sector | Agriculture, Food and Drink,Healthcare,Pharmaceuticals and Medical Biotechnology |
Impact Types | Societal Economic |
Description | Phage Therapy to Reduce AMR Enterobacteria Spread from a One Health Perspective |
Amount | £482,880 (GBP) |
Funding ID | MR/W031248/1 |
Organisation | Medical Research Council (MRC) |
Sector | Public |
Country | United Kingdom |
Start | 02/2022 |
End | 04/2025 |
Description | The development of a phage food additive with the aim to control Salmonella in swine and poultry |
Amount | £535,882 (GBP) |
Funding ID | BB/R012822/1 |
Organisation | Biotechnology and Biological Sciences Research Council (BBSRC) |
Sector | Public |
Country | United Kingdom |
Start | 03/2018 |
End | 04/2022 |
Title | Dataset for "Reversible Trapping of Colloids in Microgrooved Channels via Diffusiophoresis under Steady-State Solute Gradients" |
Description | Experimental and simulated particle concentration fields used to generate the results shown in Fig.1, Fig. 2, Fig. 3 and Fig. 4 of "Reversible Trapping of Colloids in Microgrooved Channels via Diffusiophoresis under Steady-State Solute Gradients" by N. Singh, G. Vladisavljevic, F. Nadal, C. Cottin-Bizonne, C. Pirat, G. Bolognesi. |
Type Of Material | Database/Collection of data |
Year Produced | 2020 |
Provided To Others? | Yes |
URL | https://repository.lboro.ac.uk/articles/dataset/Dataset_for_Reversible_Trapping_of_Colloids_in_Micro... |
Title | Supplementary Information Files for Reversible trapping of colloids in microgrooved channels via diffusiophoresis under steady-state solute gradients |
Description | Supplementary Information Files for Reversible trapping of colloids in microgrooved channels via diffusiophoresis under steady-state solute gradients
The controlled transport of colloids in dead-end structures is a key capability that can enable a wide range of applications, such as bio-chemical analysis, drug delivery and underground oil recovery. This letter presents a new trapping mechanism that allows the fast (i.e., within a few minutes) and reversible accumulation of sub-micron particles within dead-end micro-grooves by means of parallel streams with different salinity level. For the first time, particle focusing in dead-end structures is achieved under steady-state gradients. Confocal microscopy analysis and numerical investigations show that the particles are trapped at a flow recirculation region within the grooves due to a combination of diffusiophoresis transport and hydrodynamic effects. Counterintuitively, the particle velocity at the focusing point is not vanishing and, hence, the particles are continuously transported in and out of the focusing point. The accumulation process is also reversible and one can cyclically trap and release the colloids by controlling the salt concentration of the streams via a flow switching valve. |
Type Of Material | Database/Collection of data |
Year Produced | 2020 |
Provided To Others? | Yes |
URL | https://repository.lboro.ac.uk/articles/dataset/Supplementary_Information_Files_for_Reversible_trapp... |
Title | Supplementary information files for A quartz crystal resonator for cellular phenotyping |
Description | Supplementary files for article A quartz crystal resonator for cellular phenotyping. Cell therapy manufacturing is limited by lack of online tools capable of realtime in-process monitoring, particularly of simultaneous changes in multiple orthogonal (mutually independent) parameters. Here, we studied changes in CD36 expression, number density and size (area) of erythroblasts through different stages of erythropoiesis in vitro using a quartz crystal resonator (QCR), integrated with a microscope, and flow cytometry in parallel. An analytical model was developed extending the Kanazawa-Gordon theory. Based on this model, independent correlations were established between changes in each QCR parameter, dissipation (?G) and resonance frequency (?-?f?_0), and CD36 expression (from flow cytometry) and cell area (from microscope). The correlation functions were used to derive an acoustic signature (-?G/??f?_0) of the differentiation process that uniquely mapped the relative changes in CD36 expression and late-stage enucleation-related deviations. A method to quantify relative changes in cell area purely from the acoustic parameters was also proposed. This work demonstrated for the first time the potential of an electromechanical tool for online monitoring of concurrently varying orthogonal phenotypic parameters in cell therapy manufacturing.
|
Type Of Material | Database/Collection of data |
Year Produced | 2020 |
Provided To Others? | Yes |
URL | https://repository.lboro.ac.uk/articles/dataset/Supplementary_information_files_for_A_quartz_crystal... |
Title | Supplementary information files for article Targeted delivery of narrow-spectrum protein antibiotics to the lower gastrointestinal tract in a murine model of Escherichia coli colonization |
Description | Supplementary information files for Targeted delivery of narrow-spectrum protein antibiotics to the lower gastrointestinal tract in a murine model of Escherichia coli colonization Bacteriocins are narrow-spectrum protein antibiotics that could potentially be used to engineer the human gut microbiota. However, technologies for targeted delivery of proteins to the lower gastrointestinal (GI) tract in preclinical animal models are currently lacking. In this work, we have developed methods for the microencapsulation of Escherichia coli targeting bacteriocins, colicin E9 and Ia, in a pH responsive formulation to allow their targeted delivery and controlled release in an in vivo murine model of E. coli colonization. Membrane emulsification was used to produce a water-in-oil emulsion with the water-soluble polymer subsequently cross-linked to produce hydrogel microcapsules. The microcapsule fabrication process allowed control of the size of the drug delivery system and a near 100% yield of the encapsulated therapeutic cargo. pH-triggered release of the encapsulated colicins was achieved using a widely available pH-responsive anionic copolymer in combination with alginate biopolymers. In vivo experiments using a murine E. coli intestinal colonization model demonstrated that oral delivery of the encapsulated colicins resulted in a significant decrease in intestinal colonization and reduction in E. coli shedding in the feces of the animals. Employing controlled release drug delivery systems such as that described here is essential to enable delivery of new protein therapeutics or other biological interventions for testing within small animal models of infection. Such approaches may have considerable value for the future development of strategies to engineer the human gut microbiota, which is central to health and disease. |
Type Of Material | Database/Collection of data |
Year Produced | 2022 |
Provided To Others? | Yes |
URL | https://repository.lboro.ac.uk/articles/dataset/Supplementary_information_files_for_article_Targeted... |
Description | A novel platform for rapid and direct detection of diarrheagenic pathogen combining nonlinear acoustic technique with molecular imprinted polymer |
Organisation | University of Leicester |
Department | Department of Cardiovascular Sciences |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Loughborough academic (Dr. Sourav Ghosh) has expertise in anharmonic (nonlinear) acoustic technique which is being used to develop a novel platform for rapid and direct detection of diarrheagenic pathogens |
Collaborator Contribution | Professor Sergey Piletsky (University of Leicester) is a leading expert in the synthesis of molecular imprinted polymers which are being developed to sense bacterial and viral epitopes. |
Impact | Project is currently underway, outputs will arise over the next 12 months. The project is multidisciplinary. The disciplines are Mechanical Engineering and Polymer Chemistry. |
Start Year | 2017 |
Description | Collaborative partnership with two NHS Trusts, for proof-of-concept study title 'Reducing misdiagnosis and antibiotic prescribing practices in hospitals: a case series review and qualitative study of diagnosis, management and treatment of urinary tract infections in adults aged over 70 years' |
Organisation | Birmingham Community Healthcare NHS Trust |
Country | United Kingdom |
Sector | Public |
PI Contribution | I am PI for the proof of concept study (£25,000 award through the EPSRC Tackling Antimicrobial Resistance Award), and study coordinator in the NHS protocol. I took responsibility for designing the study, submitting the application for NHS ethics approval and involving Patient Public Involvement Groups. |
Collaborator Contribution | Birmingham Community Healthcare NHS Trust have acted as study sponsor, and this is a multi-site study. At each of the two NHS Trust sites, a consultant microbiology is on the research team. The consultant microbiologist at BCHC is the PI for the purposes of the NHS protocol. Through BCHC NHS Trust, we have employed a NIHR network clinical research nurse to work on the study. |
Impact | Data collection started in November 2016 and is still ongoing. The collaboration is multidiscplinary with epidemiologists, social scientists, microbiologists and physicians. |
Start Year | 2016 |
Description | Collaborative partnership with two NHS Trusts, for proof-of-concept study title 'Reducing misdiagnosis and antibiotic prescribing practices in hospitals: a case series review and qualitative study of diagnosis, management and treatment of urinary tract infections in adults aged over 70 years' |
Organisation | Royal Wolverhampton Hospitals NHS Trust |
Department | Renal Unit |
Country | United Kingdom |
Sector | Hospitals |
PI Contribution | I am PI for the proof of concept study (£25,000 award through the EPSRC Tackling Antimicrobial Resistance Award), and study coordinator in the NHS protocol. I took responsibility for designing the study, submitting the application for NHS ethics approval and involving Patient Public Involvement Groups. |
Collaborator Contribution | Birmingham Community Healthcare NHS Trust have acted as study sponsor, and this is a multi-site study. At each of the two NHS Trust sites, a consultant microbiology is on the research team. The consultant microbiologist at BCHC is the PI for the purposes of the NHS protocol. Through BCHC NHS Trust, we have employed a NIHR network clinical research nurse to work on the study. |
Impact | Data collection started in November 2016 and is still ongoing. The collaboration is multidiscplinary with epidemiologists, social scientists, microbiologists and physicians. |
Start Year | 2016 |
Description | Isolation and analysis of bacteria from whole blood for rapid sepsis diagnostics |
Organisation | Royal Institute of Technology |
Department | Clinical Microfluidics Laboratory |
Country | Sweden |
Sector | Academic/University |
PI Contribution | Loughborough academics have expertise in label-free nonlinear acoustic detection technique which is being used in this collaborative project for the analysis of bacteria from whole blood for rapid sepsis diagnosis. |
Collaborator Contribution | Dr Aman Russom's group at KTH Royal Institute of Technology, Sweden, has demonstrated selective cell lysis of whole blood cells which is key to the coupling of the microfluidic blood handling part of the project and the detection. |
Impact | Project is currently underway - outputs will arise in 12 months time. This project is multidisciplinary. Dr Sourav Ghosh, Lecturer in Healthcare Engineering, Loughborough University: an acoustic sensor expert, who will lead the overall project and the ADT sensor development. Dr Aman Russom#, Associate Professor and Head of the Clinical Microfluidics lab at KTH Royal Institute of Technology, Stockholm: a clinical sample processing expert, who will lead the selective cell lysis work. Dr Volkan Özenci#, Senior Consultant and Associate Professor, Division of Clinical Microbiology, Karolinska University Hospital, Stockholm: a clinical microbiology expert, who will provide the clinical supervision in the project and host the researcher for the clinical work. |
Start Year | 2017 |
Description | To characterize the volatile metabolites for bio-profiling infecting organisms in chronic wounds |
Organisation | Cardiff Metropolitan University |
Department | School of Heath Sciences |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Loughborough has expertise in the field Volatiles profiling using mass spectrometry. This expertise is being used to identify volatile signatures arising from bacteria colonisation and infection in wounds. |
Collaborator Contribution | Expertise in wound microbiology and clinical chronic wound management and surgical treatment. |
Impact | Recent collaboration still ongoing. Outputs will arise in 12 months time. Project is multidisciplinary involving analytical sciences, microbiology and wound specialists. |
Start Year | 2017 |
Description | To characterize the volatile metabolites for bio-profiling infecting organisms in chronic wounds |
Organisation | Cardiff University |
Department | School of Medicine |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Loughborough has expertise in the field Volatiles profiling using mass spectrometry. This expertise is being used to identify volatile signatures arising from bacteria colonisation and infection in wounds. |
Collaborator Contribution | Expertise in wound microbiology and clinical chronic wound management and surgical treatment. |
Impact | Recent collaboration still ongoing. Outputs will arise in 12 months time. Project is multidisciplinary involving analytical sciences, microbiology and wound specialists. |
Start Year | 2017 |
Description | To characterize the volatile metabolites produced by strains of Pseudomonas aeruginosa |
Organisation | August Pi i Sunyer Biomedical Research Institute |
Department | Hospital Clinic of Barcelona |
Country | Spain |
Sector | Hospitals |
PI Contribution | Loughborough brings expertise in analytical sciences related to measuring volatiles in exhaled breath using mass spectrometry. |
Collaborator Contribution | Expertise in host infection and inflammation biomarkers and clinical expertise related to pneumonia. |
Impact | No outputs as yet as project has recently started. Project is multidisciplinary involving analytical sciences, immunology and clinical expertise in pneumonia. |
Start Year | 2017 |
Description | To characterize the volatile metabolites produced by strains of Pseudomonas aeruginosa |
Organisation | University of Birmingham |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Loughborough brings expertise in analytical sciences related to measuring volatiles in exhaled breath using mass spectrometry. |
Collaborator Contribution | Expertise in host infection and inflammation biomarkers and clinical expertise related to pneumonia. |
Impact | No outputs as yet as project has recently started. Project is multidisciplinary involving analytical sciences, immunology and clinical expertise in pneumonia. |
Start Year | 2017 |
Description | AMR Workshop Hosted at Loughborough |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Engaging interdisciplinary researchers/clinicians/industry/policy makers to map needs and challenges associated with AMR. Mapped clinical need and identified potential research projects to address this need. Held a series of invited seminars for clinicians and industry relevant to AMR. |
Year(s) Of Engagement Activity | 2015 |
URL | http://www.lboro.ac.uk/research/amr/ |
Description | Consultation with Patient Public Involvement Group |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Patients, carers and/or patient groups |
Results and Impact | The research team and a representative from our study sponsor attended the Leicestershire and Rutland Frail and Older Adults Patient, Public Involvement group. We wanted to discuss the acceptability of our proposed research design, and we also asked for the opinion of the group about a particular issue surrounding ethics. Following feedback from the group, we modified some of the language in our recruitment materials for the study, we also made some important notes about the concerns of the group regarding ethical procedures, and these went into the considerations of our proposal submitted to the NHS Health Research Authority. We found the engagement with the group very valuable. |
Year(s) Of Engagement Activity | 2016 |
Description | Diagnostics Workshop, 21st June 2016, Loughborough University |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Workshop focused on specific clinical theme (diagnostics) to identify clinical needs and opportunities where Loughborough with its partners could make impact. The workshop resulted in building of Interdisciplinary research teams around specific project ideas developed in workshops to address specific challenges within the clinical theme where we are best placed to make significant impact. We have successfully encouraged early career researchers to engage with the AMR research challenges by inviting them to workshops and encouraging them to take on roles as project leads. Workshops have included 'clinical problem champions' with strong support from our 'Advisory Board' to help the network better understand specific AMR challenges that we as an organisation can engage with but also to impress upon the network the national and global importance of these challenges. We have reached out to international external collaborators with a view to positioning our network to target funding through the Global Challenges Research Fund (GCRF); this will allow us to extend further research supported through the AMR network working in partnership with international institutions. |
Year(s) Of Engagement Activity | 2016 |
Description | Presentation, Federation of Infection Societies Annual Conference |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | Presentation: Misdiagnosis and antibiotic prescribing practices related to asymptomatic bacteriuria in the elderly: a case series review. |
Year(s) Of Engagement Activity | 2017 |
Description | Research Engagement, Leicester Academy for the Study of Ageing |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Professional Practitioners |
Results and Impact | We reported findings of proof-of-concept study and qualitative interviews on UTI in older adults, and in turn, sought advice and guidance on developing a new research proposal which will build on the preliminary studies. |
Year(s) Of Engagement Activity | 2018 |
Description | Wound & Biofilms Workshop 13 & 14 December 2016, Loughborough University |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Workshop focused on specific clinical theme (wounds and biofilms) to identify clinical needs and opportunities where Loughborough with its partners could make impact. The workshop resulted in building of Interdisciplinary research teams around specific project ideas developed in workshops to address specific challenges within the clinical theme where we are best placed to make significant impact. We have successfully encouraged early career researchers to engage with the AMR research challenges by inviting them to workshops and encouraging them to take on roles as project leads. Workshops have included 'clinical problem champions' with strong support from our 'Advisory Board' to help the network better understand specific AMR challenges that we as an organisation can engage with but also to impress upon the network the national and global importance of these challenges. We have reached out to international external collaborators with a view to positioning our network to target funding through the Global Challenges Research Fund (GCRF); this will allow us to extend further research supported through the AMR network working in partnership with international institutions. |
Year(s) Of Engagement Activity | 2016 |